Background: Pulmonary arterial hypertension (PAH) is one of several cardiovascular complications in patients with thalassemia, and significant cause of mortality and morbidity. The etiology is multifactorial and one of the… Click to show full abstract
Background: Pulmonary arterial hypertension (PAH) is one of several cardiovascular complications in patients with thalassemia, and significant cause of mortality and morbidity. The etiology is multifactorial and one of the important mechanisms is a decrease in nitric oxide (NO) resulting in
               
Click one of the above tabs to view related content.